The human colorectal epithelium is maintained by multipotent stem cells that give rise to absorptive, mucous, and endocrine lineages. Recent evidence suggests that human colorectal cancers are likewise maintained by a minority population of socalled cancer stem cells. We have previously established a human colorectal cancer cell line with multipotent characteristics (HRA-19) and developed a serum-free medium that induces endocrine, mucous and absorptive lineage commitment by HRA-19 cells in vitro. In this study, we investigate the role of the 1 integrin family of cell surface extracellular matrix receptors in multilineage differentiation by these multipotent human colorectal cancer cells. We show that endocrine and mucous lineage commitment is blocked in the presence of functionblocking antibodies to 1 integrin. Function-blocking antibodies to ␣2 integrin also blocked both HRA-19 endocrine lineage commitment and enterocytic differentiation by Caco-2 human colon cancer cells; both effects being abrogated by the MEK inhibitor, PD98059, suggesting a role for ERK signaling in ␣2-mediated regulation of colorectal cancer cell differentiation. To further explore the role of ␣2 integrin in multilineage differentiation, we established multipotent cells expressing high levels of wild-type ␣2 integrin or a non-signaling chimeric ␣2 integrin. Overexpression of wild-type ␣2 integrin in HRA-19 cells significantly enhanced endocrine and mucous lineage commitment, while cells expressing the non-signaling chimeric ␣2 integrin had negligible ability for either endocrine or mucous lineage commitment. This study indicates that the collagen receptor ␣21 integrin is a regulator of cell fate in human multipotent colorectal cancer cells.A small population of multipotent epithelial stem cells maintains the integrity and function of the adult intestinal epithelium (1) Colorectal epithelial stem cells proliferate slowly giving rise to daughter cells that undergo a phase of rapid proliferation and then differentiate into absorptive, mucous, and endocrine cells. Homeostasis requires a precise balance between stem cell renewal and generation of lineage-committed cells; processes regulated by the Wnt, TGF-, Hedgehog, and Notch pathways (2). Dysregulation of the Wnt signaling pathway, a critical regulator of normal stem cell renewal, is commonly present in colorectal cancer as the result of well described mutations in Wnt signaling components(3). This suggests that signaling cascades that promote normal colorectal epithelial stem cell renewal persist in colorectal cancer cells. Indeed there is growing support for the idea that human cancers, including colorectal cancer, are diseases of stem cells (4, 5). It has been shown that only a small minority of tumor cells, termed cancer stem cells, are able to initiate tumor growth. Furthermore, putative human colorectal cancer stem cells have been isolated on the basis of their expression of epithelial cell adhesion molecule and CD44 (6) or CD133 (7,8). However the relationship between cancer stem...